UVM Health proposal to Green Mountain Care Board now open for public comment
The University of Vermont Health Network is taking action to address it's financial missteps.
For the past two years, the health network has gone far beyond it's revenue cap – a number set by the care board with the purpose of reducing the amount of money a hospital can make from caring for its patients.
The total overage for fiscal year 2023 was $80 million, in 2024 it was $53 million.
For the past three months, health network officials have been working alongside members of the care board to create a proposal they claim will address affordability, access, and reaffirm their commitment to the communities they serve.
That proposal was reviewed on Wednesday.
'Members of our community, members of this board have lost trust in our decisions. When that trust is compromised, we have an obligation to make it right,' says Dr. Sunny Eappen, Chief Executive Officer of the health network.
Some of the initiatives listed in the proposal include $11 million in investments in community based primary care, sending $12 million to Blue Cross Blue Shield Vermont to resolve overpayment allegations from fiscal year 2022 and 2023, and setting aside up to $15 million to hire a liaison that would work with both the health network and care board.
'That would really be a 'how do we work towards ensuring appropriate Medicare cost coverage, appropriate growth, operations – all those things as best we can for the state,' explains deputy director Matthew Sutter.
Some members of the community, however, voiced their concern.
'I am just beyond frusturated,' exclaims Alex LeClaire or Essex Physical Therapy.
'Can someone help me understand why we Vermonters, we rate payers, are paying up to $15 million for UVM health network to get their house in order,' questions Julie Wasserman.
The proposal has yet to be approved by the care board or the health network.
It has now entered a period of public comment, which will last for a week.
Chair Owen Foster says they hope to vote on it after that period.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
30 minutes ago
- Yahoo
Opinion - We're cancer doctors. Here's why Medicare Advantage fails America's elderly.
'It's nothing,' Tom, a retired firefighter from rural Texas, thought when he had persistent stomach pain. After shedding 30 pounds in three weeks, his family physician ordered a CT scan. Tom was not concerned — after all, the 65-year-old had gotten Medicare Advantage earlier that year. Like millions, Tom switched his insurance after he was solicited by a broker who promised low premiums and a gift card. Absent from the sales pitch was the fact that Medicare Advantage plans — privately run and separate from government-funded traditional Medicare — often delay and deny coverage. One of us met Tom nearly three months after his CT scan, and his doctor discovered the abdominal mass. The job as the first oncologist he had been able to see after months of jumping through hoops was to get initial scans, identify an in-network provider, wait for further referral and approval processes and finally schedule and complete a biopsy. The delays became a death knell. Tom was diagnosed with Stage 3 pancreatic cancer. Tom's first question was, 'It's going to be fine, right?' Despite the urge to reassure him, Tom's life and treatment options were not up to a doctor. They were up to his insurance. The same insurance that delayed urgent testing and care. By definition, Medicare Advantage is meant to support elderly medical care and increase efficiencies; in function, it is a business model that allows the American government to decrease its liability for sick seniors. Instead of absorbing and managing costs, the responsibility is outsourced to third-party operators, such as UnitedHealth Group, Humana and CVS Health. While Medicare Advantage provides excellent coverage if you never get sick, this insurance can quickly become a precursor to medical bankruptcy if the patient develops a deadly disease, a highly probable outcome when you consider that nearly 40 percent of Americans get cancer in their lifetime. After nearly two decades of experimentation and $450 billion of taxpayer money, Medicare Advantage has proven porous in terms of corruption, fraud and abuse. Yet, 32.8 million elderly Americans (54 percent of the eligible Medicare population) are currently enrolled in Medicare Advantage. In 2023 alone, Medicare Advantage plans fully or partially denied 3.2 million prior authorization requests. No one, especially among folks facing the daily drudgery of fighting cancer, truly understands how the cogs within the insurance machine work. Few of our elderly patients fight the goliath institution, and many succumb to poorer health outcomes in their quest for lifesaving treatment. Last year, countrywide and across disease groups, 79 percent of patients who experienced a delay or denial of coverage paid out of pocket for medication at least sometimes. Unsurprisingly, more than 100 million Americans are in medical debt. Of those who appealed between 2019 and 2023, over 80 percent were approved, implying that the initial claims were valid. This game of attrition directly contradicts Medicare Advantage's promise to provide efficient, patient-centered healthcare. These denials are not just medically dangerous because they enable deadly diseases to progress unchecked. They are also emotionally erosive. Daily, we see patients shrink in the face of denials, unable to emotionally navigate the complex Medicare system and the immense pain, isolation and depression resulting from this behemoth that stands between their disease and their hope to be free of it. During one of Tom's chemo visits, with thousands of dollars worth of IVs in his veins, his skin pale and translucent, he realized he was begging his insurance at every turn to support him. Stories like Tom's reveal the truth: Medicare Advantage is unapologetically failing its elderly cancer patients. Sick American seniors deserve more than insurance coverage in name only. We advise our patients to avoid Medicare Advantage. The better choice is traditional Medicare, plus a secondary or supplemental insurance. Often, people do not enroll in supplemental insurance because they do not understand its importance, believe they will never get sick, miss the deadline for approval without a medical exam (you must do this within three months before or after your 65th birthday), or think it is too expensive. Although supplemental insurance costs nearly $500 a month (exact amounts vary based on age and income), choosing this add-on — and paying roughly $6,000 a year — is much more affordable than Medicare Advantage's yearly out-of-pocket (potentially adding up to $8,500) and fighting for approvals for basic treatment. On Medicare Advantage, Tom quickly reached his maximum yearly out-of-pocket of $8,500, but then it reset on Jan. 1. After four months of treatment, he was responsible for paying $17,000 for 16 months of care, on top of his insurance premiums, simply to receive standard care. Of course, if you are one of the fortunate few to have never experienced illness — and we hope you are — Medicare Advantage can be a cheaper option. The question is, how can we make Medicare Advantage advantageous for the vulnerable? There is a bipartisan opportunity to change the narrative around this insurance model. During his confirmation hearing as the head of the Centers for Medicare and Medicaid Services, Mehmet Oz criticized Medicare Advantage insurers for some of their practices. Strategic change — omitting out-of-pocket costs for cancer patients, curbing insurance companies' rights to deny claims submitted by doctors and speeding up the process — along with more rigorous oversight of the program are worthwhile goals the Trump administration and Congress should take on. While Democrats and Republicans disagree on many issues, we believe we can all agree that people like Tom — and the millions of other Americans enrolled in Medicare Advantage — deserve comprehensive and just care. Dr. Pramod Pinnamaneni, MD, MBA, and Dr. Nitya Thummalachetty, DrPH, are founders of the Nau Project, a start-up dedicated to helping everyday Americans navigate the complexities of our healthcare system. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
an hour ago
- Yahoo
UnitedHealth Seeks $1B Latin America Exit: Sources
UnitedHealth Group Incorporated (NYSE:UNH) is one of the best Dow stocks to invest in. The company is considering several offers for its Latin American business, according to two insiders familiar with the situation, as it works to recover from a series of major setbacks, including the removal of its CEO and a reported criminal accounting investigation. The largest US health insurer has aimed to exit Latin America since 2022, but selling its Banmedica unit has become more urgent recently due to multiple challenges, one source said. A senior healthcare professional giving advice to a patient in a clinic. New CEO Steve Hemsley told shareholders last week that he is focused on regaining their confidence following a disappointing earnings report and a Wall Street Journal story about a criminal probe into alleged Medicare fraud. UnitedHealth Group Incorporated (NYSE:UNH) maintains it has not been notified by the Department of Justice and stands by its business integrity. UnitedHealth Group Incorporated (NYSE:UNH) has received four non-binding bids for Banmedica, which operates in Colombia and Chile, totaling around $1 billion, according to sources who requested anonymity due to the confidential nature of the negotiations. While we acknowledge the potential of UNH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure. None. Sign in to access your portfolio
Yahoo
2 hours ago
- Yahoo
Stanford Health Care and Kivo Health Collaborate to Advance Value Based Care for COPD through Virtual Pulmonary Rehabilitation
PALO ALTO, Calif. & SAN FRANCISCO, June 11, 2025--(BUSINESS WIRE)--Stanford Health Care, one of the nation's leading academic medical centers, tapped Kivo Health as part of a collaboration to advance AI-powered virtual pulmonary rehabilitation and care for patients with Chronic Obstructive Pulmonary Disease (COPD). As part of a broader initiative to deliver high-value care, Stanford Health Care is focused on delivering innovative care for common, costly, chronic conditions such as COPD. While pulmonary rehabilitation is the gold standard of care for COPD - resulting in 56% fewer hospitalizations and improved quality of life - fewer than 3% of those who could benefit, ever have access to this life altering intervention. By collaborating with Kivo Health, Stanford Health Care enables thousands of patients to complete pulmonary rehabilitation from the safety and comfort of their homes, improving outcomes for COPD patients, and keeping patients healthy and out of the hospital. "We are thrilled to collaborate with Kivo Health to bring virtual pulmonary rehabilitation to our COPD patients," said Leah Rosengaus, Senior Director of Digital Health at Stanford Health Care. "We are dedicated to enhancing access to care, and believe innovative solutions like virtual pulmonary rehabilitation provide patients with new channels to connect to services, and support healing in the comfort of home." "This collaboration reflects a bold commitment to evidence-based innovation, health equity, and value-based care," said Victor Sadauskas, MD, CEO of Kivo Health. "Together, we are transforming how COPD is managed—expanding access, improving outcomes, and dramatically reducing avoidable hospitalizations for one of the most underserved, highest-cost chronic conditions in the U.S." For more information about Stanford Health Care and Kivo Health, visit and About Stanford Health Care Stanford Health Care seeks to heal humanity through science and compassion, one patient at a time, through its commitment to care, educate and discover. Stanford Health Care delivers clinical innovation across its inpatient services, specialty health centers, physician offices, virtual care offerings and health plan programs. Stanford Health Care is part of Stanford Medicine, a leading academic health system that includes the Stanford University School of Medicine, Stanford Health Care, and Stanford Children's Health, with Lucile Packard Children's Hospital. Stanford Medicine is renowned for breakthroughs in treating cancer, heart disease, brain disorders and surgical and medical conditions. For more information, visit: About Kivo Health Kivo Health provides AI-powered virtual rehab and care for people with COPD. Kivo's Medicare-covered program improves patient symptoms while reducing costs of care by keeping patients healthy and at home. View source version on Contacts Kivo HealthVictor Sadauskascontact@ Sign in to access your portfolio
